Northwest & Ethical Investments’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Sell
1,335
-3,281
-71% -$682K 0.01% 369
2026
Q1
$981K Buy
4,616
+2,151
+87% +$463K 0.02% 313
2025
Q4
$511K Buy
2,465
+508
+26% +$95.6K 0.01% 396
2025
Q3
$303K Sell
1,957
-3,690
-65% -$570K 0.01% 441
2025
Q2
$944K Sell
5,647
-800
-12% -$119K 0.02% 330
2025
Q1
$887K Buy
+6,447
New +$822K 0.02% 343
2017
Q4
Sell
-37,035
Closed -$2.48M 352
2017
Q3
$2.48M Sell
37,035
-12,091
-25% -$855K 0.15% 178
2017
Q2
$3.83M Sell
49,126
-362
-0.7% -$27.3K 0.26% 104
2017
Q1
$4.04M Buy
49,488
+13,740
+38% +$1.08M 0.27% 100
2016
Q4
$2.57M Buy
35,748
+1,382
+4% +$99.9K 0.18% 147
2016
Q3
$2.67M Buy
34,366
+9,641
+39% +$779K 0.19% 130
2016
Q2
$1.93M Buy
+24,725
New +$1.97M 0.15% 142

Other funds holding CAH

Northwest & Ethical Investments's CAH Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Cardinal Health (CAH) stake by 71% in Q2 2026, selling an estimated $682K and leaving 1,335 shares worth $315K. The position accounts for 0.01% of the portfolio, ranked #369.

Northwest & Ethical Investments first reported a position in CAH in Q2 2016 and has held it in 12 quarters since. The position peaked at $4.04M in Q1 2017. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Northwest & Ethical Investments held 1,335 shares of Cardinal Health worth $315K as of Q2 2026.
  • Northwest & Ethical Investments sold 3,281 Cardinal Health shares in Q2 2026, an estimated $682K.
  • Cardinal Health made up 0.01% of Northwest & Ethical Investments's portfolio in Q2 2026, its #369 holding.
  • Northwest & Ethical Investments first reported a position in Cardinal Health in Q2 2016 and has held it in 12 quarters since.
  • Northwest & Ethical Investments's Cardinal Health position peaked at $4.04M in Q1 2017.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.